This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraine- on migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis. Issue 2 (17th December 2021)
Record Type:
Journal Article
Title:
Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraine- on migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis. Issue 2 (17th December 2021)
Main Title:
Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraine- on migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis